Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

RainDance Launches the Next Generation of PCR

Published: Tuesday, April 03, 2012
Last Updated: Tuesday, April 03, 2012
Bookmark and Share
New RainDrop™ System surpasses all existing digital PCR technologies and establishes new performance standards in cancer research.

RainDance Technologies, Inc. has introduced its new RainDrop™ Digital PCR System, which establishes new performance standards in sensitivity, multiplexing and absolute quantitation in PCR analysis. Capable of generating more than a billion reactions in a single day, the RainDrop System transforms the performance of molecular assays by enabling digital answers across a number of important applications including low-frequency tumor allele detection, gene expression, copy number variation, and SNP measurement. RainDance unveiled the new RainDrop System this week at the annual meeting of the American Association for Cancer Research (AACR) in Chicago.

Built on RainDance’s patented and proven RainStorm™ picodroplet technology, the RainDrop System generates up to 10 million picoliter-sized droplets per lane. Since each droplet encapsulates a single molecule, researchers can quickly determine the absolute number of droplets containing specific target DNA and compare that to the number of droplets with background wild-type DNA. The RainDrop System also shifts the current digital PCR (dPCR) paradigm from a single-color-per-marker approach to a two color and varying probe intensity method that is capable of multiplexing up to 10 markers.(1)
In a recent Lab on a Chip paper,(2) scientists from Université de Strasbourg and Université Paris Descartes, used the RainDance dPCR technology to detect a single mutated copy of KRAS in a background of 200,000 wild-type copies. By processing reactions in millions of picoliter droplets, the platform improved sensitivity by two orders of magnitude compared to existing technologies.

“With RainDance digital PCR, we were able to achieve absolute quantification of mutated and tumor-circulating DNA and improve the detection of a circulating tumor by comparing its proportion to non-tumor DNA,” added Professor Pierre Laurent-Puig, M.D., Ph.D. of the Université Paris Descartes. “Absolute quantification is critical, especially in research that lays the groundwork for future clinical applications, because it allows you to generate meaningful thresholds that will be required for prognostic and diagnostic tools.”

“Two years ago, RainDance embarked on an ambitious goal when it set out to develop a digital PCR technology platform that would fundamentally transform cancer research, and open the door to new ways that cancers may be detected, monitored and treated in the future,” said Roopom Banerjee, President and CEO of RainDance Technologies. “With the introduction of our RainDrop System at AACR, we have realized this vision and officially ushered in the next generation of PCR. As several of our early customers have demonstrated at this meeting, we will soon have absolute answers to many of the most complex questions in cancer research and tumor progression.”

Beginning in the summer of 2012, RainDance will be offering a select number of scientists the opportunity to participate in the RainDrop First Access Program. This multi-day program will consist of both classroom and wet-lab sessions. During the classroom sessions, participants will interact with the senior RainDance scientists responsible for developing this dPCR technology. The wet-lab sessions will provide hands-on instrumentation and software training with assays and samples. Participants will also be able to choose from a fixed menu of assays and run up to 32 of their own samples.

RainDance will be showcasing the new RainDrop System at AACR in booth #2706.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Best Test to Diagnose Strangles in Horses Identified
New research by Dr. Ashley Boyle of New Bolton Center’s Equine Field Service team shows that the best method for diagnosing Strangles in horses is to take samples from a horse’s guttural pouch and analyze them using a loop-mediated amplification (LAMP) polymerase chain reaction (PCR) test.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
Detecting When Hormone Treatment for Breast Cancer Stops Working
Scientists have developed a highly sensitive blood test that can spot when breast cancers become resistant to standard hormone treatment, and have demonstrated that this test could guide further treatment.
Packaging and Unpacking of the Genome
New research improves understanding of the importance of histone replacement.
New Way to Find DNA Damage
University of Utah chemists devised a new way to detect chemical damage to DNA that sometimes leads to genetic mutations responsible for many diseases, including various cancers and neurological disorders.
How Different Treatments for Crohn's Effect the Microbiome
Different treatments for Crohn's disease in children affects their gut microbes in distinct ways, which has implications for future development of microbial-targeted therapies for these patients, according to a study led by researchers from the Perelman School of Medicine at the University of Pennsylvania.
Charting the 'Genomic Biography' of Leukemia
A new study by scientists at Dana-Farber Cancer Institute and the Broad Institute of MIT and Harvard offers a glimpse of the wealth of information that can be gleaned by combing the genome of a large collection of leukemia tissue samples.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos